https://www.selleckchem.com/pr....oducts/blasticidin-s
01). AcH3 and BRCA1 were expressed in all samples. There was a significant decrease in cytoplasmic BRCA1 expression in the poorly differentiated group, suggesting BRCA1 as a possible prognostic marker for SCC-MT. AcH3 and BRCA1 were expressed in all samples. There was a significant decrease in cytoplasmic BRCA1 expression in the poorly differentiated group, suggesting BRCA1 as a possible prognostic marker for SCC-MT. Knowing the prevalence and predictors of neuropathic pain and its impacts on the quality of life (QoL) using me
Like
Comment
Share
